Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie(The Royal Melbourne Hospital), Peter Gibbs(The University of Melbourne), Hui‐Li Wong(Walter and Eliza Hall Institute of Medical Research), Mark Tacey(The University of Melbourne), Natalie Silliman(University of South Carolina), Nickolas Papadopoulos(Johns Hopkins University), Theresa Hayes(St John of God Hospital), Luis A. Díaz(Memorial Sloan Kettering Cancer Center), Simeon Springer(Howard Hughes Medical Institute), Kenneth W. Kinzler(Johns Hopkins University), Timothy Price(Basil Hetzel Institute), Michael Christie(Hudson Institute of Medical Research), Isaac Kinde(Sidney Kimmel Cancer Center), Bert Vogelstein(Johns Hopkins University), Malcolm Steel(Eastern Health), Jayesh Desai(Peter MacCallum Cancer Centre), Ian T. Jones(The Royal Melbourne Hospital), Suzanne Kosmider(Western Health), Rachel Wong(Box Hill Hospital), Andrew Haydon(The Alfred Hospital), Yuxuan Wang(Beijing Anzhen Hospital), Lu Li(Johns Hopkins University), Ben Tran(The University of Melbourne), Cristian Tomasetti(Quantitative BioSciences), Robert L. Strausberg(Ludwig Cancer Research), Iain Skinner(Western Health)
Cited by 1,466
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k